Cooley represented the former board of directors of Sequenom in a nearly seven-year-long securities class action brought by former investors in the company. In July 2016,...
You must be a Standard 1 Year member to access this content.
Cooley advised Sierra Ventures on the fundraising. Sierra Ventures announced its $265 million Fund XIII – which is approximately 20% larger than its previous fund. Proceeds...
You must be a Standard 1 Year member to access this content.
Cooley advised Battery Ventures on the deal. GrammaTech announced that Battery Ventures has acquired its software products division, including the CodeSonar and CodeSentry product lines. The...
You must be a Standard 1 Year member to access this content.
Cooley advised Tenable on the deal. Tenable Holdings, Inc. (Nasdaq: TENB) announced that it has signed a definitive agreement to acquire Ermetic Ltd. for a purchase...
You must be a Standard 1 Year member to access this content.
Haynes and Boone, LLP and Klehr Harrison Harvey Branzburg LLP advised Brand Engagement Network Inc., and Cooley LLP advised DHC Acquisition Corp. on the transaction. Brand...
You must be a Standard 1 Year member to access this content.
Veirano Advogados and Cooley advised QED, while Bronstein, Zilberberg, Chueiri & Potenza Advogados and Wilson Sonsini Goodrich & Rosati advised Mottu on the deal. Mottu Locação...
You must be a Standard 1 Year member to access this content.
Cooley advised Dutch Bros, and Latham & Watkins advised the underwriters. Dutch Bros Inc. (NYSE: BROS; Dutch Bros) announced the pricing of an underwritten offering of...
You must be a Standard 1 Year member to access this content.
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
You must be a Standard 1 Year member to access this content.
Cooley advised Zepto on the fundraising. Zepto announced its $200 million Series E financing, which brings its valuation to $1.4 billion. StepStone Group led the financing round,...
You must be a Standard 1 Year member to access this content.
Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
You must be a Standard 1 Year member to access this content.
Cooley advised Ramp on the fundraising. Ramp announced a $300 million Series D on the back of strong revenue growth, rapidly increasing market share among small...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
You must be a Standard 1 Year member to access this content.
